Feride Yilmaz

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study.

Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study.

Journal: BMC cancer

Published: November 30, 2025

Prostatic Solitary Fibrous Tumor With Pulmonary Metastases: A Case Report.

Prostatic Solitary Fibrous Tumor With Pulmonary Metastases: A Case Report.

Journal: Cureus

Published: October 16, 2025

A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value.

A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value.

Journal: Journal of clinical medicine

Published: June 01, 2025

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel.

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel.

Journal: Medicina (Kaunas, Lithuania)

Published: May 04, 2025

Prognostic value of the StAN score in elderly small cell lung cancer.

Prognostic value of the StAN score in elderly small cell lung cancer.

Journal: Scientific reports

Published: March 19, 2025

Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial.

Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial.

Journal: Targeted oncology

Published: August 28, 2024

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.

Journal: BMC cancer

Published: June 06, 2024

Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study.

Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study.

Journal: Cancers

Published: May 04, 2024

Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study.

Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study.

Journal: Annals of surgical oncology

Published: December 19, 2023

Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohort.

Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohort.

Journal: Medicine

Published: May 05, 2023

Emerging treatment strategies in hepatobiliary cancer.

Emerging treatment strategies in hepatobiliary cancer.

Journal: Expert review of anticancer therapy

Published: February 21, 2023

The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.

The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: October 25, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026